BYSI (BeyondSpring Inc.) Stock Market Reviews

crown

search

Read and share opinions on BYSI (BeyondSpring Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock market.

BYSI

BeyondSpring Inc.

clarify Biotechnology

bookmark Healthcare

public United States

Sell Neutral Buy

Latest News

BeyondSpring Presents Efficacy/Safety Data from a Phase 2 Study of Pembrolizumab plus Plinabulin/Docetaxel in Metastatic NSCLC after Progressing on First-Line Immune Checkpoint Inhibitors at 2025 ASCO Annual Meeting
Jun 3, 2025
BeyondSpring Announces Poster Presentation at 2025 ASCO Annual Meeting
May 28, 2025
BeyondSpring Reports First‑Quarter 2025 Financial Results and Provides Corporate Update
May 12, 2025
BeyondSpring Files 2024 Annual Report on Form 10-K
Mar 27, 2025
BeyondSpring Announces $35.4 Million Sale of a Portion of Equity Interest in SEED Therapeutics to Advance Lead Asset Plinabulin to Anti-Cancer Registrational Studies
Jan 28, 2025

Reviews